September 30, 2022
Article
The depth and durability of responses seen with these CAR T-cell therapies in refractory myeloma is unprecedented and raises again the question of the role of up-front autologous stem cell transplant in the era of immune therapies, including CAR T-cell therapies.
December 22, 2020
Video
Saad Usmani, MD, speculates on the current progress in treating multiple myeloma, while providing a glimpse into the future of cutting-edge treatments.
December 22, 2020
Video
Saad Usmani, MD, reflects on the impact the coronavirus pandemic has had on his practice and the treatment of patients with multiple myeloma overall.
December 22, 2020
Video
The MAIA & PEGASUS Trial and Managing Patients Receiving DRd
December 22, 2020
Video
Saad Usmani, MD, analyzes the efficacy and safety data results from the phase 3 MAIA study.
December 22, 2020
Video
Saad Usmani, MD, discusses what first-line options are available for patients with multiple myeloma while highlighting the difficulties in defining high-risk characteristics associated with multiple myeloma.